Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Inflammatory Bowel Diseases

• A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Ass
• Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
• Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
• Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study
• Study of Tolerability, Safety, and Pharmacokinetics of ZL-82 in Healthy Adult Subjects.
• Efficacy and Safety of Lactulose for Bowel Preparation in Patients With Inflammatory Bowel Disease
• Vancomycin in Primary Sclerosing Cholangitis in Italy
• Xylitol Use for Decolonization of C. Difficile in Patients With IBD
• Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects
• Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
• Fenofibrate in Ulcerative Colitis
• Oral Nano Vitamin D Supplementation Efficacy in Inflammatory Bowel Disease
• Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
• Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease
• Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
• LMT503 First-in-human SAD, MAD, and FE Study
• A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.
• Cholecalciferol in Chronic Inflammatory Bowel Diseases
• A Phase 2b Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
• ASC - Autism Pilot Study
• Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor-α Agents in Patients With Inflammatory Bowel Disease
• High Dose Steroid to Treat Flares in Inflammatory Bowel Disease
• Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.
• Stem Cells for the Treatment of Pouchitis
• Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
• Metformin as Added on Therapy in Patients With Ulcerative Colitis
• Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
• Atorvastatin in Patients With Ulcerative Colitis
• Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
• Metformin in Patients With Ulcerative Colitis Treated With Mesalamine
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
• A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel Disease
• Predicting Response to Iron Supplementation in Patients With Inflammatory Bowel Disease During Induction Therapy
• Examining the Effect of Ondansetron on Bowel Prep Success
• Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
• Safety of Reduced Infliximab Infusion Time
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
• Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study
• Safety and Pharmacokinetics of Oral Controlled-ileocolonic-release Nicotinamide (CICR-NAM)
• Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
• The Nordic IBD Treatment Strategy Trial
• Response To Medical Therapy in Inflammatory Bowel Disease Patients Carrying-out a Prescribed Exercise Programme
• Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
• Terbinafine Treatment of Axial Spondyloarthropathy
• Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants
• Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
• Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease
• Cholecalciferol Comedication in IBD - the 5C Study
• Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases
• The MIRO II Study: Microbial Restoration in Inflammatory Bowel Diseases
• Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
• Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease
• N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease
• Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis
• Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
• Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
• A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT
• Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy
• Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks
• Chronotherapy in Inflammatory Bowel Disease
• Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
• Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease
• Control Crohn Safe Trial
• Phase I Clinical Trial in Healthy Male Volunteers
• Folic Acid in Pediatric Inflammatory Bowel Disease
• Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
• Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
• ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
• Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
• Multiple Dose Ethnobridging PK Study in Healthy Subjects
• Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
• Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
• Bowel Preparation in Elective Pediatric Intestinal Surgery
• Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
• Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
• Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease
• A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
• Perioperative Dexamethasone on Postoperative Outcome in IBD
• Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients
• TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
• Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
• GSK2983559 First Time in Human Study
• Differences in Preparation for Small Bowel Capsule Endoscopy
• Preoperative Oral ImmunoNuTrition to Improve Surgical Outcomes for IBD Patients (PINT)
• A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
• The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
• A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
• Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
• Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
• Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
• The ICON Study: Outcomes After FMT for Patients With IBD and CDI
• Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
• GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )
• Vitamin D Substitution During Winter Time
• Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
• Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
• Prucalopride Prior to Small Bowel Capsule Endoscopy
• Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
• Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
• Managing Infliximab Reinduction After Temporary Discontinuation of Drug
• Anemia in Inflammatory Bowel Disease
• Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
• Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
• PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers
• An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
• A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques
• TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease
• Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease
• Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
• A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
• Fecal Microbiota Transplant for Inflammatory Bowel Disease
• Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab
• The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
• "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
• Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
• Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• Corticosteroid Dosage for Crohn's Disease Flare
• On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
• Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects
• Thiopurine Induced Pancreatitis in IBD Patients
• Low Volume Colon Preparation for IBD
• Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)
• Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
• Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
• Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
• Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
• Preparation Prior to Colonoscopy in Children
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
• Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease
• Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
• Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response
• Early Serum Infliximab Levels in Severe Ulcerative Colitis.
• Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy
• Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening
• Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine
• Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
• Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease
• Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
• Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
• The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease
• Vitamin D Treatment in Ulcerative Colitis
• Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease
• Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
• Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)
• Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy
• Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program
• IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
• Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy
• Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
• A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
• Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
• A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
• Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease
• Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine
• A Trial of Iron Replacement in Patients With Iron Deficiency.
• Cannabis for Inflammatory Bowel Disease
• Cannabidiol for Inflammatory Bowel Disease
• First Time in Human Study of Intravenous Interleukin-18 Antibody
• Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
• Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
• An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
• Functional Restoration After Abdominal and Pelvic Laparoscopic Surgery: Effect of Perioperative Intravenous Lidocaine
• Curcumin in Pediatric Inflammatory Bowel Disease
• Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
• Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose
• Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
• SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
• Maintenance Treatment of Iron Deficiency in IBD Patients
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
• Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
• A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
• Thalidomide in Pediatric Inflammatory Bowel Diseases.
• Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease
• Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole
• A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
• Gene Regulation by Thiazolidinediones
• Cost-effectiveness of TPMT Pharmacogenetics
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
• Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
• Sirolimus for Autoimmune Disease of Blood Cells
• Dietary Treatment of Crohn's Disease
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
• Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
• MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
• Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
• A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.
• The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
• Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
• Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
• A Trial of Rosiglitazone for Ulcerative Colitis
• Clotrimazole Enemas for Pouchitis in Children and Adults
• Study Evaluating rhIL-11 in Active Crohn's Disease
• Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
• A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease